Skin-on-a-Chip Model for Rare Skin Disease

Protheragen’s innovative Skin-on-a-Chip model replicates the physiological and pathological features of human skin using advanced microfluidic technology and patient-derived cells. This platform enables 3D tissue cultivation and disease-specific microenvironment simulation, providing critical insights into rare skin diseases and supporting the development of targeted treatments.

Applications of Skin-on-a-Chip Model

• Disease Modeling & Target Validation: Our models accurately mimic rare skin disease environments, enabling the identification and validation of biomarkers and therapeutic targets.
• Model Construction & Optimization: Built with advanced microfluidic systems, our platforms ensure precise replication of skin structure, offering high reliability for research and testing.
• Drug Screening & Toxicity Assessment: Enables efficient screening of therapeutic compounds, evaluating their efficacy and toxicity in physiologically relevant conditions.
• Mechanistic Insights & Functional Analysis: Provides comprehensive insights into cellular interactions, inflammatory responses, and disease mechanisms, advancing innovative therapeutic strategies.
• Preclinical Validation: Offers robust data on efficacy and safety in controlled microenvironments, supporting the development of new therapies.

Protheragen aims to drive advancements in developing the skin-on-a-chip model for rare skin disease and are committed to assisting our partners in pioneering cutting-edge therapies. If you are interested in our services, please contact us as soon as possible.

Relative Services

In addition to offering customized Skin-on-a-Chip model development services, Protheragen also provide a wide range of cell-based and animal model development solutions.

Cell-based Models Development

• Cell Line Development
• Primary Cell Development
• iPSC Development

Organoid Models Development

Animal Models Development

• Genetically Engineering Model
• Non-Genetically Engineering Model
• Syngeneic Model
• Xenograft Model
• Humanized Animal Model

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

• Rare Disease Diagnostics Development
• Rare Disease Therapeutics Development
• Drug Repurposing Service
• Rare Disease Model Development Services
• Drug Safety Evaluation Services
• Pharmacokinetics Services